Metformin, a popular blood sugar medication, could help reduce hospitalizations from COVID-19 and the dreaded long-term health effects from the infection known as long COVID, a recent study has revealed.
A team of researchers from the University of Minnesota discovered that the use of metformin can reduce the amount of COVID-19 virus in the body, which decides the severity of the infection. It also lowers the risk of viral rebound, a condition that causes the virus to come back strongly after initial treatment.
